Former Boston Scientific Vascular Access Devices Now Sold Under New Name
August 5, 2008 – Navilyst Medical, formerly Boston Scientific’s Fluid Management and Vascular Access businesses, yesterday announced its new company name and global debut, following the February 2008 acquisition by Avista Capital Partners.
Navilyst Medical manufactures and markets a portfolio of fluid management and vascular access products used during some of the most frequent hospital procedures including angiography and angioplasty. The company’s Fluid Management business includes the proprietary NAMIC line of products, while its vascular access products include devices designed to provide access to the blood stream for patients requiring intravenous antibiotics, nutrition, chemotherapy, blood sampling and hemodialysis. Navilyst’s PASV Technology, with strong clinical data, is uniquely designed to automatically close after infusion, disconnection or aspiration, and remain closed during normal pressure fluctuations, reducing the risk of complications including catheter-related bloodstream infections.
Navilyst’s products are distributed in 76 countries and are sold direct in the U.S. The company is reportedly on track to launch several new products into the global marketplace through internal development and strategic alliances during the upcoming year.
For more information: www.navilystmedical.com, www.avistacap.com
More like this
- AngioDynamics to Acquire Navilyst Medical for $372 Million
- Navilyst Introduces New Contrast Injection Products at AVA
- Boston Scientific to Sell Fluid Management, Venous Access Businesses
- 3 French Vaxcel PICC Adds to Valve Technology
- Boston Scientific to Sell Fluid Management, Venous Access to Avista for $425 Million